Gene therapy for ALS delivers
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 27 (5) , 235-238
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS ModelScience, 2003
- Intramuscular Grafts of Myoblasts Genetically Modified to Secrete Glial Cell Line-Derived Neurotrophic Factor Prevent Motoneuron Loss and Disease Progression in a Mouse Model of Familial Amyotrophic Lateral SclerosisHuman Gene Therapy, 1999
- A controlled trial of recombinant methionyl human BDNF in ALSNeurology, 1999
- A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosisNeurology, 1998
- Effect of recombinant human insulin-like growth factor-I on progression of ALSNeurology, 1997
- A double‐blind placebo‐controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosisNeurology, 1996
- Members of several gene families influence survival of rat motoneurons in vitro and in vivoJournal of Neuroscience Research, 1993
- Insulin‐like growth factors: Putative muscle‐derived trophic agents that promote motoneuron survivalJournal of Neurobiology, 1993
- Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitroJournal of the Neurological Sciences, 1992
- Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors.Journal of Cell Biology, 1990